Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcus aureus genomic DNA represents the complete set of genetic information required for the growth, survival, and virulence of this Gram-positive pathogen (NCBI, 2023). It typically consists of a circular chromosome of approximately 2.8 megabases, often accompanied by extrachromosomal plasmids that carry resistance and virulence genes (PubMed, 2018). This genomic material serves as the essential template for DNA replication and RNA transcription, processes that are vital for bacterial proliferation (Nature Reviews Microbiology, 2015). In clinical medicine, S. aureus genomic DNA is a primary target for diagnostic assays, where specific sequences like the nuc gene or the mecA gene are used to identify the species and determine methicillin resistance (StatPearls, 2023). Many classes of antibiotics exert their effects by interacting with the DNA or the enzymes that manage its topology; for example, fluoroquinolones stabilize DNA-enzyme cleavage complexes, leading to lethal chromosomal fragmentation (PubMed, 2021). Additionally, DNA-damaging agents like metronidazole can cause direct strand breaks in the genomic sequence under specific metabolic conditions (StatPearls, 2023). The high plasticity of the S. aureus genome, driven by horizontal gene transfer and mutations, presents a significant challenge in treating infections due to the rapid emergence of multi-drug resistant strains (Nature Reviews Microbiology, 2015).
Inhibition of DNA replication and transcription through the stabilization of DNA-protein cleavage complexes, direct induction of DNA strand breaks, or inhibition of RNA polymerase binding to the DNA template.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus genomic DNA (S. aureus gDNA).